Intravenous urea in treatment of bone-pain crises of sickle-cell disease. A double-blind trial.
D000293:Adolescent; D000328:Adult; D000755:Anemia, Sickle Cell / Q000150:complications*; D001806:Blood Urea Nitrogen; D001847:Bone Diseases / Q000188:drug therapy* / Q000209:etiology; D002648:Child; D002986:Clinical Trials as Topic; D004357:Drug Synergism; D005260:Female; D005632:Fructose / Q000627:therapeutic use; D005947:Glucose / Q000627:therapeutic use; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D010146:Pain / Q000188:drug therapy* / Q000209:etiology; D011188:Potassium / Q000097:blood; D012964:Sodium / Q000097:blood; D013997:Time Factors; D014508:Urea / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use
D005632:Fructose; D014508:Urea; D012964:Sodium; D005947:Glucose; D011188:Potassium